Evidence map›Paper›PMID 38345145›Full record

ArticleAnnals of neurology2024

Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.

Anthony Chomyk, Rikki Kucinski, Jihye Kim, Emilie Christie, Kaitlyn Cyncynatus, Zachary Gossman, Zhihong Chen, Brian Richardson, Mark Cameron, Tim Turner and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Anthony ChomykDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Rikki KucinskiDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Jihye KimDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Emilie ChristieDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Kaitlyn CyncynatusDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Zachary GossmanDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Zhihong ChenDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Brian RichardsonDepartment of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Mark CameronDepartment of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Tim TurnerSanofi, Cambridge, Massachusetts, USA.
Ranjan DuttaDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0001-8502-4455
Bruce TrappDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0001-6682-3737
Cleveland Clinic Lerner College of Medicine · USCase Western Reserve University · USSanofi (United States) · US

Funding

Pathogenesis of Neurological Disability in Primary Diseases of MyelinR35NS097303 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI TRAPP, BRUCE D · 2017 to 2024
$6.9M
Understanding role of circadian disruption in pathogenesis of MSR01NS123532 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI Ranjan Dutta, sujata Rao · 2022 to 2026
$2.2M
NINDS NIH HHS R35NS09730NINDS NIH HHS R35 NS097303
6 · The paper itself

Abstract

objectiveMicroglia/macrophages line the border of demyelinated lesions in both cerebral white matter and the cortex in the brains of multiple sclerosis patients. Microglia/macrophages associated with chronic white matter lesions are thought to be responsible for slow lesion expansion and disability progression in progressive multiple sclerosis, whereas those lining gray matter lesions are less studied. Profiling these microglia/macrophages could help to focus therapies on genes or pathways specific to lesion expansion and disease progression.

methodsWe compared the morphology and transcript profiles of microglia/macrophages associated with borders of white matter (WM line) and subpial gray matter lesions (GM line) using laser capture microscopy. We performed RNA sequencing on isolated cells followed by immunocytochemistry to determine the distribution of translational products of transcripts increased in WM line microglia.

resultsCells in the WM line appear activated, with shorter processes and larger cell bodies, whereas those in the GM line appear more homeostatic, with smaller cell bodies and multiple thin processes. Transcript profiling revealed 176 genes in WM lines and 111 genes in GM lines as differentially expressed. Transcripts associated with immune activation and iron homeostasis were increased in WM line microglia, whereas genes belonging to the canonical Wnt signaling pathway were increased in GM line microglia.

interpretationWe propose that the mechanisms of demyelination and dynamics of lesion expansion are responsible for differential transcript expression in WM lines and GM lines, and posit that increased expression of the Fc epsilon receptor, spleen tyrosine kinase, and Bruton's tyrosine kinase, play a key role in regulating microglia/macrophage function at the border of chronic active white matter lesions. ANN NEUROL 2024;95:907-916.

Indexed as

Gray MatterMacrophagesMicrogliaMultiple SclerosisWhite MatterAdultAgedFemaleHumansMaleMiddle AgedTranscriptome

Identifiers

PMID38345145
PMCPMC11060930
OpenAlexW4391753711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.